New Publication

Written By ExoMira Medicine

CHICAGO, IL; May 2023: Congratulations to ExoMira CSO Dr. Andrew Hoffmann and the team under the supervision of ExoMira cofounders Drs. Fang and Liu at Northwestern University published the single-cell RNA seq research article on COVID-19 immunity in Clinical Immunology (05-17-2023).

ExoMira Medicine

ExoMira Medicine Inc. (“ExoMira”) is a Chicago-based preclinical-stage pharmaceutical company (a spin-off from Northwestern University) focused on developing innovative cancer immunotherapies.

Previous

New Presentation
Next

New Involvement